Dupixent 300 mg solution for injection in pre-filled pen clinical trials

Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study

This study looks at how a medicine called Dupixent affects the lining of the nose in people with long-term sinus problems and polyps. It aims to see if the medicine helps strengthen this lining and reduce their symptoms.